The effect of gensing on sexual function in postmenopausal women with major depressio
- Conditions
- Major depression.Depressive episode
- Registration Number
- IRCT20120718010324N74
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 66
Postmenopausal women with major depressive disorder confirmed by the psychiatrist colleague of the research team
Age 40-65 years
Having a steady sexual partner
Having sexual intercourse at least once a month
At least 12 months have passed since their last period.
FSFI score less than 28
No change in treatment plan during the past and future 2 months (including no current treatment, stable use of antidepressants, or continuous non-pharmacological treatment)
Having reading and writing literacy
Having chronic diseases, including cardiovascular, liver, diabetes, kidney and endocrine diseases, according to medical records
Hormone therapy for any reason during the last 2 months
Blood pressure above 140/90 based on measurement by the researcher and medical records
Continuous use of other herbal medicines
Taking medications that interfere with ginseng, such as diabetes medications, immunosuppressants, and warfarin
Having a history of allergy to herbal medicines
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sexual function. Timepoint: Before and after the end of intervention. Method of measurement: Female Sexual Function Index.
- Secondary Outcome Measures
Name Time Method Menopausal symptoms. Timepoint: Before and after the end of intervention. Method of measurement: Green scale.;Depression. Timepoint: Before and after the end of intervention. Method of measurement: Beck depression questionnaire.;Side events. Timepoint: During the intervention. Method of measurement: Side events checklist.